News Archive of Burrill Report

Pfizer Ups Offer for AstraZeneca to $119B05-18-14
FDA Rejects Novartis? Serelaxin for Acute Heart Failure05-16-14
Abbott Buys Chile's CFR Pharmaceuticals for $2.9B05-16-14
Shedding Non-Core Assets05-16-14
Expanding the Building Blocks of DNA 05-14-14
FDA Approves Merck's Zontivity 05-09-14
Researchers Use Patient's Own T-cells to Attack Cancer05-09-14
Bayer Buys Merck's Consumer Medicines for $14.2B05-09-14
Avalanche Teams with Regeneron in $640M Deal05-09-14
Payers, Pricing, and Their Trust Issues with Pharma 05-07-14
AstraZeneca Rejects Sweetened Pfizer Offer05-02-14
Scientists Find Potential Key to Reverse Aging05-05-14
Study Finds Significant Increase in Diabetes among U.S. Youth05-04-14
ALS Patients Launch $139M Investment Fund05-02-14
AstraZeneca Rejects Pfizer's Sweetened Offer05-02-14
Why the FDA Should Learn from Itself05-01-14
GSK and Novartis Swap Assets in Multi-Billion Dollar Deal04-25-14
Zimmer to Acquire Biomet for $13.35B04-26-14
Celgene Pays Nogra Pharma $710M Upfront for Late-Stage Crohn's Disease Drug04-25-14
FDA Proposes Early Access Pathway for Breakthrough Medical Devices 04-25-14
Saving U.S. Biomedical Research from Itself 04-23-14
Scripps Initiative Nabs J&J Innovation as First Collaborator04-17-14
Privately Held Life Sciences Companies Raise $1.5B so Far in April04-18-14
Comparative Effectiveness Studies of Cancer Drugs Is Costly04-21-14
Pfizer and AstraZeneca Team with Cancer Research UK to Advance Personalized Medicine 04-18-14
Scripps? Initiative Nabs J & J Innovation as First Collaborator04-17-14
The Rise in Drug Spending and What It Means04-17-14
Study Highlights Opportunities to Reduce Spending on Costly Specialty Drugs 04-11-14
Biotech IPOs Cool Amid Market Jitters04-13-14
HHS Secretary Sebelius Resigns04-13-14
Mallinckrodt To Buy Questcor for $5.6 Billion04-11-14
Personalizing Cancer Therapies with a Mouse04-10-14
Intarcia Lands $200M for Disruptive Drug Delivery04-04-14
AbbVie Drops Attempt to Block EU Clinical Trial Transparency Effort04-04-14
Forma Therapeutics and Celgene Form $600M Alliance04-04-14
Stem Cells Improve Heart Function04-04-14
A Growing Tension Between Innovation and Price04-03-14
Axonics Raises $32.6 M for Implantable Neuromodulation Technology03-27-14
Axonics Raises $32.6 M for Implantable Neurmodulation Technology03-27-14
Baxter to Split into Two Companies03-27-14
Global Telehealth Initiative Launched03-27-14
New Procedure Converts Stem Cells into Muscle Cells03-27-14
Why There's Growing Talk of a Biotech Bubble 03-26-14
IBM's Watson to Help Clinicians Tackle Brain Cancer03-23-14
Lawmakers Ask Gilead for Details on Pricing Sovaldi 03-23-14
Life Sciences IPOs Top $2B03-20-14
Five Prime Therapeutics in $350M Deal with Bristol-Myers Squibb03-18-14
Democratizing Venture Investing03-20-14
Circassia $333M IPO in London Lifts European Hopes03-14-14
Alector and Janssen Partner for Alzheimer's Therapies03-14-14
Circassia's $333M IPO in London Lifts European Hopes03-14-14
CIRM Allocates Funds, Adopts Reforms03-14-14
UK to Launch Early Access to Medicines03-14-14
Challenges Remain to Clinical Use of Sequencing03-13-14
Venter Launches Human Longevity with $70M03-09-14
New Hope for Brain Cancer03-09-14
Evidence Lacking on Value-based Purchasing in Healthcare03-09-14
AstraZeneca Partners with Korean Health Institute03-09-14
Expanding Access to Experimental ALS Drugs03-06-14
Study Casts Doubt on Benefits of the Medical Home03-03-14
Celgene Taps Abide Therapeutics for Enzyme Targeting Technology03-03-14
Biotech Continues Hot Streak in U.S. Markets03-03-14
FDA approves AstraZeneca Therapy for Rare Disease02-28-14
A Transplant Bank Flush with Opportunity02-27-14
Novimmune Banks $66M to Advance Pipeline02-21-14
Actavis to buy Forest Labs for $25 Billion02-23-14
Cell Therapy Shows Promise in Leukemia Battle 02-23-14
NBA Taps Wearable Tech to Track Player Vitals02-23-14
The Case for Megamergers02-21-14
Partners to Leverage $117M for Antibiotic Discovery02-16-14
Mallinckrodt Pays $1.3B for Cadence Pharma02-16-14
Life Sciences IPOs Keep On Coming02-17-14
Partners to Leverage $117 for Antibiotic Discovery02-16-14
FDA approves BioMarin's Vimizim for enzyme disorder02-16-14
Mallinckrodt Pays $1.3 Billion Cadence Pharma02-16-14
What 2014 Looks Like for Drug Launches02-10-14
Banner Week for Biotech IPOs in U.S.02-07-14
The Game is On02-06-14
BIO Argues for Unique Biosimilar Naming02-07-14
NIH's Collins Discusses Partnership with Industry02-06-14
Merck Inks Collaborations with Amgen, Incyte, and Pfizer02-06-14
Five More Biotechs Go Public02-05-14
Biotech IPOs Off and Running 01-31-14
Non-profit Inks MS Deal with NIH01-27-14
Ensuring Results Are Reproducible01-30-14
Breakthrough Designation Proves Elusive01-31-14
Ensuring Results Are Reproducable01-30-14
DioGenix Reports Positive Results for Next-Gen MS Test 01-27-14
U.S. Public Biotechs Raise Almost One Billion in Equity and Debt01-24-14
Janssen Puts Focus on Global Public Health01-24-14
Reaching a Personalized Medicine Milestone01-24-14
Vigilance Called for as FDA Speeds Approvals01-23-14
IMS Urges Big Pharma to Dive into Social Media01-22-14
Moderna Signs Rare Disease Pact with Alexion and Launches Onkaido 01-17-14
Regeneron and Geisinger to Sequence 100k Genomes01-18-14
FDA Issues Draft Social Media Guidance01-17-14
Regenerative Medicine Gets Ready for Prime Time 01-16-14
Sanofi Invests $700M in Rare Disease Specialist Alnylam01-16-14
Big Pharma Faces Tougher M&A Landscape01-10-14
New Clues as to How Bacteria Evade Antibiotics01-10-14
Why We Need Sleep01-10-14
Johnson & Johnson Looks to Israel for Innovation01-10-14
FDA Reviewer Flunks Chelsea's Fainting Drug Ahead of Advisory Meeting, Shares Tank01-10-14
Forest Laboratories to Acquire Aptalis for $2.9B01-09-14
Thermo Fisher Sells Assets to GE Healthcare for $1.1B01-08-14
Global Life Sciences M&A Deal Values Hit $131.8B in 201301-06-14
Drugmakers Launch Data-sharing Site01-03-14
FDA Rebuffs Genzyme's Lemtrada for Relapsing MS01-02-14
Asia's Share of Biomedical R&D Investment Grows01-03-14
A Look at 2013, the J.P. Morgan Conference, and Beyond01-02-14
Banner Year for Life Sciences IPOs12-29-13
Buyout Firm Acquires Majority Stake in Ikaria12-27-13
Tesaro Reports Positive Results, but Not Good Enough as Investors Sink Shares12-27-13
Fighting Cancer with Gene Therapy12-26-13
Alzheimer's Disease Unraveled12-26-13
Merck Launches New Weight Management Business12-26-13
AstraZeneca Banks on Diabetes 12-23-13
UCSF Chancellor Leaving to Head Gates Foundation12-20-13
Fixing the Life Sciences with the Lean Startup12-19-13
Biotech Visionary G. Steven Burrill Offers Predictions for 201412-19-13
Targacept Ends Another Program, Shares Tumble12-19-13
Biogen and Samsung to Market Biosimilars in Europe12-18-13
Covidien Buys Given Imaging for $860M12-15-13
Roche Taps Prothena for Parkinson's Drug12-15-13
Avanir Falls as MS Drug Misses Primary Endpoint in Mid-Stage Trial12-15-13
Biotech Visionary G. Steven Burrill Offers Predictions for 201412-19-13
Biogen and Samsung to Market Biosimilars in Europe12-18-13
UCSF Chancellor Leaving to Head Gates Foundation12-20-13
Fixing the Life Sciences with the Lean Startup12-19-13
Covidien Buys Given Imaging for $860M12-15-13
Roche Taps Prothena for Parkinson's Drug12-15-13
Avanir Falls as MS Drug Misses Primary Endpoint in Mid-Stage Trial12-15-13
Global R&D Spending to Grow 3.8 Percent in 201412-13-13
Scientists Create Drug Response Biosensor 12-13-13
Making the U.S. More Competitive12-13-13
G8 Seeks Dementia Cure by 202512-12-13
Why Standards Are Needed to Fix Life Sciences Research12-12-13
FDA Approves Breakthrough Therapy for Hepatitis C12-08-13
Cancer Research Centers Partner to Launch Juno with $120M Series A12-08-13
Three Biotechs Secure Billion Dollar Partnerships12-06-13
23andMe Suspends Health-Related Gene Tests12-08-13
Lilly Discontinues Development of Experimental Drug for Major Depressive Disorder12-05-13
Pharma Faces Shrinking Returns from Innovation12-05-13
Editas Medicine Launches with $43M in Funding11-30-13
FDA Warns 23andMe to Stop Selling its DNA Tests12-01-13
Editas Medicine Launched with $43M in Funding11-30-13
Egalet Teams with Shionogi in $425M Deal11-29-13
Why Pharma Companies Are Looking More Like Biotechs 11-28-13
Global Drug Spending to Reach $1 Trillion in 201411-24-13
Sanofi Discontinues Development of Fedratinib11-22-13
VCs Launch Two Biotechs Focused on the Gut11-22-13
FDA Approves First Next-Gen Sequencer as Diagnostic11-22-13
Clovis Oncology Acquires Ethical Oncology Science for Up to $420M11-22-13
Royal DSM and JLL Create $2.6B CMO11-22-13
A Common Ground for Discussing Healthcare11-21-13
Immatics and Roche Sign Cancer Deal Worth Up to $1B11-15-13
Life Sciences IPO Fever Cools11-15-13
Sarepta Plummets after FDA says NDA Filing for Eteplirsen Premature11-15-13
Global Diabetes Pandemic Shows No Sign of Abating11-15-13
FDA Gives OK for Imbruvica to Treat Rare Blood Cancer11-15-13
Fixing a $30 Billion a Year Healthcare Problem11-14-13
Shire to Buy ViroPharma for $4.2B11-12-13
FDA Looks to Eliminate Trans Fats from Food 11-07-13
Roche Enters Antibiotics Partnership with Polyphor11-05-13
U.K. Caps Government Drug Spend 11-08-13
Salix to pay $2.6B for Santaris11-08-13
Robust Pace of Financings Continues11-08-13
New Senate Bill Could Be Boon to Biotechs11-08-13
Cytori Attracts Strategic Investment from Asia Partner 11-07-13
Payers Target Rising Specialty Drug Spend11-01-13
Life Sciences Companies Up 41 Percent Since IPOs in 2013 11-01-13
Study Finds Neglected Diseases Remain So10-30-13
Why a Tiny Canadian Biotech Suddenly has Big Ambitions10-31-13
Mixed Results for Payer-Pharma Collaborations10-30-13
Employers Push Workers toward Healthier Choices10-30-13
Paying for Outcomes Extends to Drugs10-30-13
Customer Excellence: Business Model Innovation for MedTechs10-29-13
Get it on the Record10-25-13
Locking in Early-Stage Assets10-25-13
SEC Issues Proposed Crowdfunding Rules10-25-13
Practice Fusion Draws Ire over Reviews10-25-13
Glooko Awaits FDA Nod to Expand Diabetes Data Service10-25-13
The Most Common Genetic Mutation in Alzheimer's Disease is Double Trouble10-23-13
Epirus Biopharma to Develop Biosimilars in Brazil10-24-13
Hair-Raising Research10-24-13
Why You Shouldn't Bank on Wall Street's Drug Forecasts 10-24-13
Spark Therapeutics Launched with $50M to Advance Gene Therapy Trials10-24-13
Name Game10-18-13
Early-stage Biotechs Getting Funded10-17-13
Witty Calls on U.K. to Invest in Innovation through Universities10-18-13
AstraZeneca's MedImmune Acquires Spirogen for Up to $440 Million 10-17-13
IBM and Cleveland Clinic Put Watson to Work10-18-13
What the Surging IPO Market Means for Venture Investment 10-17-13
PureTech Ventures Teams with Non-Profit JDRF 10-16-13
E.U. Cancer Costs Differ Substantially Between Countries10-15-13
California Governor Vetoes Biosimilar Bill10-14-13
St. Jude Medical Acquires NanoStim for at least $123.5M10-14-13
Clinical Trials Results Move the Market10-10-13
Crowdfunding Early-Stage Drug Development10-11-13
New Drug and Device Reviews Still on Hold at FDA10-11-13
Spit Here for Guidance10-10-13
Diversify and De-risk10-10-13
German Watchdog Wants Trials Data Made Public10-10-13
Why Drug Development Is No Longer Just for Pharma 10-10-13
Green Shoots of Productivity10-10-13
LDR Holding Raises $75M in IPO 10-09-13
UK Pursues Large-Scale Genomic Sequencing Project10-08-13
Mitokyne Partners with Astellas in $730M Deal10-08-13
Device Tax Foes Seize Opportunity in Budget Impasse10-04-13
Intrexon Invests in Consumer-Focused ?Living Art? Company10-04-13
Wearable Health Tech Revenue Trends Toward $6B by 201810-04-13
Fate Therapeutics? IPO Comes in Below Initial Target10-04-13
Lilly Still Plans on Meeting 2014 Goals10-03-13
Merck Makes Global Cuts to Save $2.5B10-03-13
Princess Di, Faked Moon Landings, and the Denial of Science10-04-13
Big Data Comes to the Farm10-04-13
One Budget Solution Hits The Wall10-04-13
Geisinger Allies with Genomics Researchers To Fight Liver Disease10-04-13
What Winners Do to Beat the M&A Odds 10-03-13
Funding a Personalized Immunotherapy for MS10-03-13
The October 2013 Issue of The Burrill Report09-29-13
JPMorgan, Gates to Create Investment Fund for Late-Stage Global Health Technologies09-26-13
Lessons for the Newly Insured 09-27-13
AbbVie Invests $45M in Expanded Galapagos Partnership09-27-13
Roche Teams with PacBio In Deal Worth Up To $75M09-26-13
Separating a Boom from a Bubble 09-26-13
Three Biotech IPOs Raise $298 M09-25-13
Ablynx Scores $175M Upfront in Licensing Deal with AbbVie09-23-13
FDA Finalizes Mobile Medical Apps Guidance09-23-13
Regado CEO sees IPO as a Success09-20-13
Our Hands-Free Future09-20-13
From Field To Bench09-19-13
Building a Better Cancer Drug 09-19-13
Acceleron Prices Upsized IPO at Top of Range09-19-13
Google Takes on Aging with Former CEO of Genentech09-19-13
Drug Ads Often Misleading09-19-13
CDC Issues Call to Arms on Drug-Resistant Bugs09-18-13
Progress Against Cancer Tempered by Challenge09-18-13
Teva and Cancer Research Technology Form R&D Alliance 09-18-13
Five Prime Therapeutics IPO Raises $62M09-18-13
FDA Blocks Imports from Ranbaxy Facilities09-17-13
A Tale of Two Outbreaks09-17-13
Long-Term Care Advisors See More Work Ahead09-16-13
Roche Will Develop Inovio's Preclinical Cancer Vaccine09-13-13
Lilly Brings $500M Arbitration Claim Against Canada09-13-13
Stepping with the Oldies09-12-13
Theranos to Offer Lab Tests through Walgreens09-13-13
Paying Docs for Performance Improves Outcomes09-13-13
Gilead Seeks Approval for its First Cancer Therapy09-12-13
OvaScience Tussles with FDA Over Trial09-12-13
Developing Vaccines for the Deadliest Diseases09-12-13
Why I Decided Not to Get Cancer09-12-13
Hospira Gains First Biosimilar Approval in EU09-10-13
Biogen Expands Antisense Bet with $100M Isis Deal09-10-13
Tick, Tock, Progress09-06-13
Syndax Looks East for Pharma Partner09-06-13
UltraGenyx Collaborates with Kyowa Hakko Kirin09-06-13
The New China Syndrome09-06-13
NIH Grants $20 Million to Sequence Infant Genomes09-06-13
BioMérieux to Buy BioFire Diagnostics for $450 M09-05-13
Otsuka Buys Astex for $886 Million09-05-13
Baxter and Coherus Collaborate on Biosimilars09-05-13
Cytokinetics Heart Failure Drug Misses Mark09-05-13
Bringing Personalized Medicine to Ovarian Cancer 09-04-13
CIRM Tries to Be Friendlier to Business08-30-13
California Law Could Constrain Biosimilar Substitutions08-30-13
J&J Targets Dengue Fever08-30-13
Increased Longevity Comes at a Price08-30-13
Lilly and Humana Collaborate to Improve Outcomes08-30-13
AstraZeneca's MedImmune to Buy Amplimmune for up to $500M 08-30-13
The September 2013 Issue of The Burrill Report08-30-13
Food for Thought08-29-13
Sangamo Makes Strategic Gene Therapy Buy08-29-13
Australia Unveils $250M Medical Innovation Fund08-26-13
Amgen to Acquire Onyx for $10.4 Billion08-25-13
Seeing Dead People08-23-13
Regado Biosciences Completes Downsized IPO08-23-13
TransCelerate Biopharma Launches Comparator Network08-22-13
Immune Pharmaceuticals and EpiCept Combine 08-23-13
Building a Profitable Biotech 08-23-13
In Doctors We Trust08-23-13
Employer-Sponsored Family Health Premiums Rise 4 Percent08-22-13
Novartis Gains Third Breakthrough Designation08-22-13
St. Jude Medical Acquires Endosense for up to $331 million08-22-13
Curing Cancer with the Wisdom and Money of Crowds08-22-13
VCs Buy into Royalty Stream08-16-13
Seattle BioMed Receives $16.6M for TB Research08-16-13
FDA Backs ?Organs-on-Chip? with $5.6 Million Grant08-15-13
VC Exits Grow, But Funds Dwindle08-15-13
Unfit for Residency08-15-13
Early-Stage Funding Gets a Boost08-15-13
Pharmstandard to Acquire Bever Pharmaceutical for $590M08-14-13
Fitbit Zero08-14-13
FDA Approves Viiv Healthcare's New HIV Drug08-13-13
Vical Suffers Drubbing After Late-Stage Failure08-12-13
Medtronic Buys Cardiocom for $200M08-12-13
Cloud-based Continuous Heart Monitor Wins CE Mark08-12-13
Faster, Cheaper, Earlier Diabetes Test Gets $7M Boost08-09-13
GE and UW Partner to Develop On-Demand Diagnostics08-09-13
Better to Burn Out than to Fade Away08-09-13
GSK Launches $50M Fund Targeting Bioeletronics08-08-13
Intrexon Surges 54.6 Percent on IPO Debut08-07-13
Test Sees HIV Early, Fast08-08-13
Array Cuts 20 Percent of Workforce 08-08-13
Measuring Pharma Innovation08-08-13
FDA Updates ?Plug-and-Play? Standards08-07-13
Novartis Breast Cancer Drug Fails Trial 08-07-13
Compugen Strikes $540M Cancer Pact with Bayer08-07-13
Top Health IT Coordinator Departing HHS08-07-13
One Served08-06-13
Duane Roth, California Industry Leader, dies at 6308-04-13
Threatening Orphans08-02-13
Sequestration Cuts $4M From Long-term Heart Disease Study 08-02-13
Cubist to Buy Optimer and Trius for more than $1.6 billion 08-02-13
Summer Heatwave for IPOs08-02-13
When Cancer Is Not Cancer08-02-13
California to Create Network of Stem Cell Clinics for Trials 08-01-13
Pfizer Pays $491 Million in Off-label Marketing Settlement07-31-13
Celgene Takes $100M Option on Acetylon07-30-13
Telegraph Hill Partners Raises $310 Million Fund07-29-13
Perrigo to Acquire Elan in $8.6 Billion Deal07-29-13
Pfizer Chases Rejuvenation with Reorg07-29-13
Five Biotech IPOs Debut in Busy Week07-26-13
GSK Says China Scandal Will Impact Earnings07-27-13
Adimab Licenses Technology to GSK and Biogen Idec07-26-13
Industry Groups Outline Principles for Transparency07-26-13
Researchers Identify New Drug Target for Parkinson's Disease07-26-13
GSK Reaches $229 Million Settlment with Eight States07-26-13
Venture Capital Dollars Move Back to Biotech07-25-13
The August 2013 Issue of The Burrill Report07-25-13
South Korea Promises $9B for New Drugs07-25-13
A Measles Outbreak, Vaccination, and the Persistence of Fear 07-25-13
Biotech Sizzles in Public Markets 07-19-13
Avastin As Good As Lucentis for Wet AMD at a Tenth of the Price07-19-13
Gene Therapy Startup Audentes Therapeutics Raises $30M07-19-13
National Institute of Health Cancels Clinical Trials in India07-18-13
Avastin As Good As Lucentis for Wet AMD at a tenth the Price07-19-13
Symplmed Sees Value in Being Direct07-18-13
Researchers Gain Understanding of Obesity Gene07-17-13
Ayasdi Raises $30.6 million for Big Data Platform07-17-13
National Cancer Institute Opens Database of Genetic Variation of Cancer07-17-13
Ipsen Acquires Syntaxin, strikes R&D deal with Harvard07-17-13
Biohackers Find a New Home in Carlsbad07-17-13
Fighting the Flu without Vaccines07-12-13
China Arrests GSK Employees for Alleged Bribery and Tax Violations07-12-13
Loxo Oncology Strikes $434 M Cancer Deal with Array BioPharma07-12-13
Bio-based Industries to Get $5 Billion Boost from European Commission07-12-13
Forma Therapeutics Teams with Cancer Research Technology07-11-13
FDA Plans to Give Generic Drugmakers Power to Change Labels07-11-13
Crescendo Personalizes Rheumatoid Arthritis Disease Management 07-11-13
Italian Pharma Backs UniQure's Gene Therapy07-11-13
Senate Seeks to Grow NIH Budget for Fiscal 201407-10-13
Immunocore Signs Deal with GSK Potentially Worth More Than $500M07-09-13
Novartis Strikes Vaccines Deal with Biological E07-09-13
SEC Investigates Call Options Trading of Onyx Pharmaceuticals Stock07-05-13
Biogen licenses Myelin Repair Foundation Tech in Fight Against MS07-03-13
California Life Sciences Companies Lead in Venture Financings07-05-13
Cardio3 BioSciences Goes Public07-05-13
Will Harlem Be the Next Hotspot for Innovation?07-08-13
FDA Gives Antibacterial Drug Developers New Guidance07-03-13
Biogen licenses Myelin Repair Foundation Tech in Fight Agains MS07-03-13
Genentech Strikes Immunotherapy Deal with Immunocore07-03-13
Eisai Suspends Sales of Anti-epileptic Drug Fycompa In Germany07-02-13
Unique Treatment for Type 1 Diabetes Shows Promise07-02-13
Astellas Provides New Muscle to Cytokinetics with Collaboration06-28-13
Monsanto Taps Nimbus Discovery in Crop Protection Pact 06-28-13
Decision Misprision06-28-13
Viehbacher Threatens to Cut Sanofi R&D Spending in Europe06-28-13
Resverlogix Tanks Following Failure of Lead Drug06-28-13
Prosensa IPO Hits the Market Running 06-28-13
Biggest Advancers and Decliners First Half of 201306-28-13
IPO Performance First Half of 201306-28-13
The July 2013 Issue of The Burrill Report06-28-13
Returning to Growth06-28-13
Roche and AstraZeneca to Share Early-Stage Data06-27-13
Sandoz Advances Enbrel Biosimilar06-26-13
SCOTUS Decision Limits Liability for Generic Drugmakers06-26-13
Breakthrough Therapies06-21-13
Illumina Ordered to Pay $115 Million Plus Interest For Patent Infringement 06-21-13
Improper Use of Drugs Wastes More than $200 Billion a Year06-21-13
Bluebird Bio Soars in Market Debut06-21-13
How Innovative Have Drugmakers Really Been?06-20-13
NGM Partners with MedImmune06-19-13
EU Commission Fines Drugmakers $194M Over Pay-for-Delay06-19-13
NIH Expands Repurposing Efforts with New Grants06-18-13
AMA Says Obesity Is a Disease06-18-13
Elan Shareholders Vote to Nix Royalty Pharma Takeover06-17-13
SCOTUS Rules Pay-For-Delay Settlements Can Violate Antitrust Laws06-17-13
J&J Bets up to $1 Billion in Aragon Buy06-17-13
Pfizer Reaches $2.15B Patent Dispute with Teva and Sun06-14-13
Amgen Invests $25 Million to Expand Cytokinetics Agreement06-14-13
Cigna Deal Bulks up Catamaran's Muscle06-14-13
SCOTUS Rules Genes Can?t Be Patented06-13-13
G8 Science Ministers Spotlight Antibiotics Resistance06-13-13
Cocktail of Generics as Good as Enbrel for Rheumatoid Arthritis06-13-13
U.S. Enjoys a Near $1 Trillion Payoff from Human Genome Project06-12-13
GE Healthcare to Invest $2 Billion in Software Development over Five Years06-11-13
BioLineRx Partners with Chinese Pharma on Hepatitis C Drug06-11-13
AstraZeneca to Buy Pearl for up to $1.15B06-10-13
Burrill & Company Indices06-10-13
Supreme Court Backs DNA Collection in Arrests06-07-13
Sanofi's Possible PARP-1 Inhibitor Fails Late-Stage Trial06-07-13
Pfizer Taps CytomX's ADC Technology in Cancer06-07-13
International Alliance Seeks to Share Genomic and Clinical Data 06-07-13
Maxygen to Dissolve06-07-13
Sourcing Innovation06-06-13
New Class of Antibiotics on the Horizon06-06-13
Bill Gates Leads Investment in Open Science Initiative06-05-13
AstraZeneca Ends Development of Rigel's RA Drug06-05-13
With ASCO Underway, Cancer Results in the News06-04-13
GSK Licenses MorphoSys Anti-Inflammatory for $29.4 Million06-03-13
GSK Preps Next-Generation Vaccines with $325M Okairos Acquisition05-31-13
CIRM Chief to Seek Funding for Stem Cell Clinics05-31-13
Ophthotech Raises $175 million for Eye Therapy05-31-13
AstraZeneca Snaps Up Omthera for as Much as $443 Million05-31-13
Biomarker For Pancreatic Cancer Identified05-31-13
QB3 Lands More Big Pharma Muscle to Launch Startups05-31-13
Allon Therapeutics, Satori Pharmaceuticals, and Predictive Biosciences to Close Shop05-30-13
Valeant Buys Bausch + Lomb for $8.7 Billion05-31-13
Amgen Allies with Astellas in Japan05-31-13
Epizyme Offering Makes May Biggest Month for Biotech IPOs in 13 Years05-30-13
The June 2013 Issue of The Burrill Report05-30-13
Elan Strikes More Deals, Rejects Sweetened Royalty Pharma Bid05-24-13
GSK and BARDA Collaborate to Develop New Antibiotics 05-23-13
Pfizer Drug Fails Three Late-stage Trials05-22-13
Industry Advocates Ally to Lobby for Tax Reforms05-24-13
Stem Cell Policy Group Folds Tent05-23-13
A Hammer in Search of a Nail05-24-13
Gates Foundation Helps Repurpose Exubera Technology05-24-13
Actavis Buys Warner Chilcott05-24-13
What Wall Street's Watching at ASCO05-22-13
Obama Administration Offers $1 Billion for Healthcare Innovation05-17-13
Pharma to Support Early-Stage Biotechs05-17-13
Scientists Report Human Stem Cell Cloning Success05-17-13
Supreme Court Rules Unanimously in Favor of Monsanto05-16-13
Saving Normal05-16-13
AbbVie Options Alvine Celiac Drug for $70 Million05-15-13
Elan Buys Stake in Theravance Royalties on Drugs05-15-13
Carmat to Implant its Artificial Heart in Human Patients05-15-13
Lack of Intestinal Bacteria Linked to Obesity05-15-13
Astellas to Consolidate R&D 05-15-13
Drug Recalls Up Over Last Year05-15-13
Synthetic Bio Research Courted with $20 Million Call05-14-13
Readmission Rates in Europe05-13-13
U.S. Trade Representative Puts Focus on Indian IP Issues05-10-13
First Tracheal Implant Performed in the United States05-10-13
Already an Internet Favorite, Pfizer Takes Viagra Sales Online05-10-13
Lilly's Late-Stage Lymphoma Drug Fails 05-10-13
Patent Expirations Help Cut Drug Spending in 201205-10-13
Baxter Alzheimer's Late-Stage Candidate Fails05-10-13
Florida Eases the Way for Biosimilars05-10-13
What Transparency Means for Healthcare05-09-13
Spate of Life Science IPOs Ready to Debut05-07-13
Healthcare Spending Projections May Be Overstated by $770B05-07-13
Celgene Strikes A Deal with Concert05-07-13
The May 2013 Issue of The Burrill Report05-03-13
Regulus CEO Praises JOBS Act05-03-13
New Hormone Holds Promise for Diabetics05-03-13
Natera Lands $54.6 Million to Tranform Pre-Natal Testing05-03-13
Atlas Ventures Closes $265 Million Fund05-03-13
Merck and Pfizer Collaborate on Diabetes Drug05-03-13
Capital Royalty Raises $805 Million Fund05-03-13
Aveo and Astellas Trial Fails to Impress Advisory Panel05-03-13
European Court Enjoins EMA from Releasing AbbVie, InterMune Data05-03-13
Ambrx Strikes Deal with Bristol-Myers for ADC Technology05-03-13
Why Gene Therapy Is Coming of Age05-02-13
Doctors Worldwide Call for Lower Cancer Drug Prices04-25-13
GSK Teams with Avalon to Fund San Diego Biotechs04-26-13
Ocera Therapeutics Going Public in Merger with Tranzyme04-26-13
Vaccine Makers Face Global Challenges04-26-13
Novartis Faces Federal Claims of Kickbacks in Civil Court04-26-13
Theravance Splitting in Two 04-26-13
Global Biotech Survey Highlights Romania, United Arab Emirates04-26-13
AstraZeneca Makes a String of Early-Stage Deals04-26-13
AstraZeneca Makes String of Early-Stage Deals04-24-13
Bill Introduced to Require Labeling of Genetically Engineered Foods04-26-13
Why Biotechs Need to Adapt to the Value-Based World04-23-13
Incentives Reward Surgical Complications04-19-13
Allecra Debuts with $19.5 Million in Funding04-19-13
FDA Won?t Approve Generic Oxycontin04-19-13
Supreme Court Hears Oral Arguments in Myriad case04-19-13
Royalty Pharma Moves to Acquire Elan04-19-13
Celltrion Drops Late-Stage Trial of Roche Rituxan Drug Copy04-18-13
Thermo Fisher Acquires Life Tech for $13.6B04-19-13
U.S. Regulators Lag European Counterparts in Protecting Patients, Report Says04-18-13
Back to that Same Old Place04-18-13
Chimerix and Omthera Go Public in Upsized Offerings04-12-13
Lilly Seeks Savings in Salesforce Cuts04-10-13
GSK Offers $1 Million Prize for Brain Breakthroughs04-11-13
Precision Medicine Meets Antibiotics04-11-13
Seeking Drug Savings, But Risking Safety04-11-13
Obama Budget Raises Ire of PhRMA, BIO04-11-13
Practice Makes Perfect04-10-13
GSK Trial Shows Encouraging Results for Duchenne MD04-10-13
Inovio and U.S. Army Receive $3.5 Million Biodefense Grant04-10-13
VistaGen Secures $36 Million04-10-13
CDC, BARDA Enlist Venter Institute to Combat H7N9 04-10-13
Gene Mutation Could Direct Prostate Cancer Care04-10-13
GSK Strikes Emerging Markets Deal with A*STAR04-09-13
Gene Therapy Startup Raises $41 Million04-08-13